PRIME II update: Omitting radiation therapy after breast-conserving surgery for older breast cancer patients

ETNK1 mutations in atypical chronic myeloid leukaemia can be reverted with phosphoethanolamine

Latest data for managing ALK NSCLC patients

FORTE: Impact of imaging FDG-PET/CT minimal residual disease assessment on multiple myeloma patients

Clinical activity and safety of cevostamab in relapsed/refractory multiple myeloma

Pregnancy outcomes in breast cancer survivors; meta-analysis

ASCEMBL: Asciminib for hard-to-treat chronic myeloid leukaemia

ASCENT: A phase II trial of induction, consolidation and maintenance in subjects with high risk smouldering MM

Inotuzumab ozogamicin in paediatric CD22-positive r/r acute lymphoblastic leukaemia: results of the ITCC-059 study

MURANO: Sustained disease survival in CLL following venetoclax plus rituximab

Comparing outcomes of first-line ibrutinib vs chemoimmunotherapy in high-risk CLL

OncoAlert and ecancer weekly roundup for November 22 - Dec 5, 2020